Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN)’s traded shares stood at 70350.0 during the last session, with the company’s beta value hitting 0.65. At the close of
In today’s recent session, 2.49 million shares of the Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) have been traded, and its beta is 0.63. Most recently the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
